Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	17.4	38.64	117.76	70.44	62.26
Short-Term Investments	8.97	20.53	0	0	41.89
Cash & Cash Equivalents	26.37	59.17	117.76	70.44	104.15
Cash Growth	-55.44%	-49.76%	67.19%	-32.37%	-18.70%
Receivables	2.9	6.27	3.31	1.71	6.79
Other Current Assets	9.42	7.98	6.55	3.58	4.07
Total Current Assets	38.68	73.42	127.63	75.72	115.01
Property, Plant & Equipment	0	20.7	23.03	25.98	22.94
Other Long-Term Assets	0	1.37	2.9	3.31	3.15
Total Long-Term Assets	0	22.07	25.94	29.29	26.08
Total Assets	38.68	95.49	153.56	105.01	141.1
Accounts Payable	3.37	4.15	8.61	1.79	5.8
Deferred Revenue	0	39.56	63.52	48.53	58.51
Current Debt	0	0.86	0	0	0
Other Current Liabilities	8.55	-7.99	-21.57	-28.17	-37.31
Total Current Liabilities	11.92	36.58	50.56	22.15	27
Long-Term Debt	0	12.24	13.84	15.93	15.48
Other Long-Term Liabilities	0	18.73	38.4	35.91	47.26
Total Long-Term Liabilities	0	30.98	52.24	51.84	62.74
Total Liabilities	11.92	67.56	102.81	73.98	89.75
Total Debt	0	13.1	13.84	15.93	15.48
Debt Growth	-	-5.33%	-13.12%	2.89%	-
Retained Earnings	-314.96	-290.42	-257.14	-211.41	-174.18
Comprehensive Income	0.03	-0.25	0.83	-0.3	-2
Shareholders' Equity	26.76	27.93	50.76	31.03	51.35
Net Cash / Debt	26.37	46.07	103.92	54.5	88.67
Net Cash / Debt Growth	-42.76%	-55.67%	90.67%	-38.53%	-30.78%
Net Cash Per Share	23.42	49.69	128.80	80.03	140.12
Working Capital	26.76	36.84	77.06	53.58	88.01
Book Value Per Share	23.77	30.12	62.91	45.56	81.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).